LentiBOOST Now Used In More Than 35 Cell Therapy Clinical Trials!
SIRION Biotech's LentiBOOST Lentiviral Transduction Reagent is used in an ever-increasing number of...
Newsroom
Meet the SIRION Biotech team at ESGCT in Edinburgh!
Booth 61, Edinburgh International Conference Center, October 11 – 14, 2022
We have a great team...
Meet our APAC team at BIO Japan in Yokohama & Partnering Conference in Osaka!
EU-Japan Biotech Pharma Partnering Conference, October 11, Osaka
BioJapan (October 12—14, Yokohama)
Meet SIRION Biotech at BioProcessing International in Boston!
Boston Convention and Exhibition CenterSeptember 27—30, Booth 631
Webinar: Identifying the Best AAV Vectors for Safer, More Potent, and Reliable Therapeutic Performance.
In this GEN webinar, our distinguished guests, Dr. Arun Srivastava and Dr. David Schaffer will tell...
SIRION Biotech Opens a New Viral Vector Research and Manufacturing Center!
We are pleased to announce that we are expanding! Our new state-of-the-art laboratories will be...
Panel Discussion at BIO 2022 – Safety Aspects of AAV and Lentivirus-based Cell and Gene Therapy
SIRION Biotech is pleased to host the panel discussion on Safety Aspects of AAV and...
Subscribe Here!
Contact Us
Whether you seek help customizing a vector for academic use or support for your industrial R&D, we will assist you from square one to discuss and plan your project in detail.
News
SIRION Biotech is now part of the Revvity portfolio!
SIRION Biotech licences its LentiBOOST® transduction technology to Cellectis
Meet us
AAV Webinar
On Demand
CAR-TCR Summit
August 29 - September 1, Boston
Meet Benjamin Eberhardt, LentiBOOST Product Manager! Eberhardt@sirion-biotech.com
Japan Society of Cell and Gene Therapy
September 11 - September 13, Osaka
BIOJapan
October 11 - October 13, Yokohama